APA (7th ed.) Citation

D, B., L, S., P, W., N, H., U, P., N, B., . . . F, H. (2021). Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF. Cardiovascular diabetology, 20(1), 7. https://doi.org/10.1186/s12933-020-01208-z

Chicago Style (17th ed.) Citation

D, Bode, et al. "Dual SGLT-1 and SGLT-2 Inhibition Improves Left Atrial Dysfunction in HFpEF." Cardiovascular Diabetology 20, no. 1 (2021): 7. https://doi.org/10.1186/s12933-020-01208-z.

MLA (9th ed.) Citation

D, Bode, et al. "Dual SGLT-1 and SGLT-2 Inhibition Improves Left Atrial Dysfunction in HFpEF." Cardiovascular Diabetology, vol. 20, no. 1, 2021, p. 7, https://doi.org/10.1186/s12933-020-01208-z.